TY - JOUR
T1 - The clinical importance of fibroblast growth factor 23 on advanced non-small cell lung cancer patients without druggable alterations in genes as EGFR or ALK or ROS1 Fibroblast growth factor 23
Y1 - 2020
PY - 2020
DA - 2020
N1 - doi:2020.60165
T2 - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JF - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JO - EJMI
SP - 365
EP - 369
VL - 4
IS - 3
SN - 
M3 - doi:2020.60165
UR - https://dx.doi.org/10.14744/ejmi.2020.60165
Y2 - 2020
ER -